| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.04 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.08 |